Oyster Point Pharma, Inc.
COMBINATIONS OF POSITIVE ALLOSTERIC MODULATORS AND NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS FOR TREATING OCULAR CONDITIONS
Last updated:
Abstract:
Described herein are methods and pharmaceutical formulations for treating dry eye disease, increasing tear production, and reducing ocular discomfort.
Status:
Application
Type:
Utility
Filling date:
8 Jan 2021
Issue date:
9 Dec 2021